Sarah Cannon Research Institute (SCRI) - Transplant and Cellular Therapy Operations is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Institute (SCRI) - Transplant and Cellular Therapy Operations has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Hematologic Malignancies, Adult.
Sponsors: Kumquat Biosciences Inc..
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Institute (SCRI) - Transplant and Cellular Therapy Operations has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Institute (SCRI) - Transplant and Cellular Therapy Operations has 1 clinical trials on record, with 1 currently active. Their work covers Hematologic Malignancies, Adult.
Sarah Cannon Research Institute (SCRI) - Transplant and Cellular Therapy Operations has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.